论文部分内容阅读
目的研讨小儿肺炎运用氧气驱动雾化器行布地奈德雾化吸入治疗的临床价值。方法从本院儿科2016年1月-12月选取966例小儿肺炎进行试验分析,按随机非盲法归组(483例/组),Ⅰ组接受常规对症治疗,Ⅱ组经氧气驱动雾化吸入布地奈德治疗,评估该两种方案的临床疗效、住院时间及相关肺炎症状缓解时间等指标。结果两组接受临床用药后,Ⅱ组患儿在总有效率(94.2%与80.1%)上相比Ⅰ组显著提高,在咳嗽/咳痰、发热及肺啰音诸症缓解上显著增快,在住院时间上显著缩短,比较差异显著(P<0.05)。结论经氧气驱动雾化器对小儿肺炎实施布地奈德雾化吸入治疗,疗效显著,有利于促进肺炎相关症状的恢复,值得加强推广。
Objective To investigate the clinical value of inhaled budesonide inhalation therapy using oxygen-driven nebulizer in children with pneumonia. Methods Nine hundred and sixty-six pediatric pneumonia patients were selected from January 2016 to December 2016 in our hospital for analysis. According to randomized non-blinding group (483 cases / group), patients in group Ⅰ received routine symptomatic treatment and in group Ⅱ, oxygen-driven inhalation Budesonide treatment to assess the clinical efficacy of the two programs, length of stay and related symptoms of pneumonia symptoms and other indicators. Results After treatment, the total effective rate (94.2% vs 80.1%) in group Ⅱ was significantly higher than that in group Ⅰ and significantly faster in relieving cough / sputum, fever and pulmonary rales, Significantly shorter hospital stay, the difference was significant (P <0.05). Conclusion Oxygen-driven nebulizer for budesonide nebulization in children with pneumonia is effective in promoting the recovery of pneumonia-related symptoms and is worth promoting.